In alignment with that hypothesis, Julich-Haertel et al. demonstrated that individuals with cirrhosis have detectable EpCAM+ AnnexinV+ EVs in similar frequencies to individuals with NSCLC and CRC.49 This evidence concerns the gene EPCAM and colorectal carcinoma.